Reckitt Benckiser Group (RB) Given “Buy” Rating at Deutsche Bank

Reckitt Benckiser Group (LON:RB)‘s stock had its “buy” rating reissued by equities research analysts at Deutsche Bank in a research report issued to clients and investors on Friday.

Several other brokerages have also recently weighed in on RB. Liberum Capital reiterated a “buy” rating and set a GBX 8,000 ($110.53) price target on shares of Reckitt Benckiser Group in a research note on Sunday, November 26th. Barclays reiterated an “equal weight” rating and set a GBX 6,600 ($91.19) price target (down previously from GBX 7,100 ($98.09)) on shares of Reckitt Benckiser Group in a research note on Monday, November 27th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 7,500 ($103.62) price target on shares of Reckitt Benckiser Group in a research note on Tuesday, December 5th. Goldman Sachs set a GBX 7,070 ($97.68) price target on shares of Reckitt Benckiser Group and gave the stock a “neutral” rating in a research note on Monday, December 11th. Finally, Kepler Capital Markets dropped their price target on shares of Reckitt Benckiser Group from GBX 7,300 ($100.86) to GBX 7,000 ($96.71) and set a “hold” rating on the stock in a research note on Monday, January 8th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and ten have given a buy rating to the stock. Reckitt Benckiser Group presently has a consensus rating of “Hold” and an average target price of GBX 7,190.87 ($99.35).

How to Become a New Pot Stock Millionaire

Shares of Reckitt Benckiser Group (LON:RB) opened at GBX 5,865 ($81.03) on Friday. Reckitt Benckiser Group has a fifty-two week low of GBX 5,562 ($76.84) and a fifty-two week high of GBX 8,110.43 ($112.05). The stock has a market cap of $39,940.00 and a P/E ratio of 2,132.73.

ILLEGAL ACTIVITY WARNING: “Reckitt Benckiser Group (RB) Given “Buy” Rating at Deutsche Bank” was published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3298371/reckitt-benckiser-group-rb-given-buy-rating-at-deutsche-bank.html.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Mineum  Achieves Market Cap of $283,900.00
Mineum Achieves Market Cap of $283,900.00
MagicCoin  Trading Down 12.9% Over Last Week
MagicCoin Trading Down 12.9% Over Last Week
Financial Comparison: Hologic  vs. Check Cap
Financial Comparison: Hologic vs. Check Cap
Cubic  Lowered to “Strong Sell” at Zacks Investment Research
Cubic Lowered to “Strong Sell” at Zacks Investment Research
$4.67 EPS Expected for Goldman Sachs  This Quarter
$4.67 EPS Expected for Goldman Sachs This Quarter
Verastem  Stock Price Down 0%
Verastem Stock Price Down 0%


© 2006-2018 Ticker Report. Google+.